Current Pharmaceutical Biotechnology
Title:Editorial (Thematic Issue: Iron Chelation and Drug Resistance in Cancer and Tuberculosis)
Volume: 15 Issue: 12
Author(s): Anil K. Sharma, Vasu Punj and Harish K. Sharma
Affiliation:
Export Options
About this article
Cite this article as:
Sharma K. Anil, Punj Vasu and Sharma K. Harish, Editorial (Thematic Issue: Iron Chelation and Drug Resistance in Cancer and Tuberculosis), Current Pharmaceutical Biotechnology 2014; 15 (12) . https://dx.doi.org/10.2174/1389201015666141121150144
DOI https://dx.doi.org/10.2174/1389201015666141121150144 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers
Medicinal Chemistry Host-Directed Therapeutics against Mycobacterial Infections
Current Pharmaceutical Design Methods for Docking Small Molecules to Macromolecules: A User’s Perspective. 2. Applications
Current Pharmaceutical Design Identification of Bostrycin Derivatives as Potential Inhibitors of Mycobacterium tuberculosis Protein Tyrosine Phosphatase (MptpB)
Medicinal Chemistry Non-Invasive Immunization on the Skin Using DNA Vaccine
Current Drug Delivery Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery
Infectious Disorders - Drug Targets Natural and Acquired Macrolide Resistance in Mycobacteria
Current Drug Targets - Infectious Disorders Novel Approach for the Synthesis of Pyrrolo[2,1-c][1,4]Benzoxazines and Pyrrolo[1,2-a]Quinoxalines
Combinatorial Chemistry & High Throughput Screening The Interplay of Disease Modifying Anti Rheumatic Drugs and Tuberculin Skin Test
Current Reviews in Clinical and Experimental Pharmacology Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis
Letters in Drug Design & Discovery Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones
Mini-Reviews in Medicinal Chemistry Selected Pharmaceutical Excipient Prevent Isoniazid and Rifampicin Induced Hepatotoxicity
Current Drug Metabolism Guinea Pig Model of Infectious Disease - Viral Infections
Current Drug Targets Review of Common Sequence Alignment Methods: Clues to Enhance Reliability
Current Genomics Inhibition of Drug Efflux in Mycobacteria with Phenothiazines and Other Putative Efflux Inhibitors
Recent Patents on Anti-Infective Drug Discovery Cyanide Detoxifying Enzyme: Rhodanese
Current Biotechnology 3D-QSAR and Molecular Docking Studies of Pyrazole Derivatives as Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium tuberculosis
Letters in Drug Design & Discovery Old and New Strategies for the Discovery of Antibacterial Agents
Current Medicinal Chemistry - Anti-Infective Agents Functional PLGA NPs for Oral Drug Delivery: Recent Strategies and Developments
Mini-Reviews in Medicinal Chemistry Interaction Between Two Residues in the Inter-Domain Interface of Escherichia coli Peptidase N Modulates Catalytic Activity
Protein & Peptide Letters